Equity Profile
Pre-Earnings Brief
Loews Corporation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Adaptive Biotechnologies Corporation specializes in using the immune system to develop diagnostics and therapeutics. As a player in the healthcare sector, it focuses on life sciences tools and services, which are increasingly important for personalized medicine and disease management.
Revenue Growth
Investors will be keen to see if the company can show significant revenue growth, indicating demand for its products.
Earnings Per Share (EPS)
EPS is a key indicator of profitability and will help gauge the company's financial health.
Wall Street expectations, options signals, track record, and call prep available with Pro.
$8.0M
Net selling
$6.3M
Net selling
$770,788.92
Net selling
Recent Transactions
Mar 11, 2026 · @ $13.17
329,600 sh
$4.3M
Mar 11, 2026 · @ $13.17
329,600 sh
$4.3M
Mar 11, 2026 · @ $13.17
140,666 sh
$1.9M
Mar 11, 2026 · @ $13.17
140,567 sh
$1.9M
Mar 11, 2026 · @ $13.17
122,523 sh
$1.6M
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.